Details

Autor(en) / Beteiligte

• Browne, J. L.
• Klipstein-Grobusch, K.
• Franx, A.
• Grobbee, D. E.

Titel

Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept

Ist Teil von

• Current cardiology reports, 2016-06, Vol.18 (6), p.59-59, Article 59

Ort / Verlag

New York: Springer US

Erscheinungsjahr

2016

Link zum Volltext

Quelle

SpringerLink

Beschreibungen/Notizen

• Nearly all of the annual 287,000 global maternal deaths are preventable. Hypertensive disorders of pregnancy (HDP) are among the major causes. A novel fixed-dose combination pill or polypill to prevent cardiovascular disease is a promising strategy for prevention of HDP. The aim of this study was to identify eligible candidates for a polypill for the prevention of HDP. A comprehensive review of systematic reviews on drug and dietary interventions to prevent HDP was conducted. Interventions were evaluated based on efficacy, dose, route of administration, and side effects. Fourteen interventions were assessed. Low-dose aspirin and calcium were identified as candidates for a polypill, with risk reduction estimations for pregnancy-induced hypertension and preeclampsia ranging between 10 and 62 %, depending on patient population characteristics including a priori risk, and gestation age at start of intervention. Their effect may be augmented through the addition of vitamin D, vitamin B 12 , and folic acid. The effect and optimal composition needs to be evaluated in future trials. Given the persistent burden of maternal and perinatal mortality associated with HDP, prevention of these disorders is key—especially in low-resource settings. The polypill approach with a combination of aspirin, calcium, vitamin D, vitamin B 12 , and folic acid is a promising strategy to improve maternal and perinatal health outcomes.